Abstract
Introduction Pregnant women are frequently excluded from clinical trials. Yet, inclusion of pregnant women is of interest in vaccinology including during health crisis. Promotion of clinical trials by midwives may facilitate the decision making of pregnant women. Attitudes of midwives about participation in a vaccine clinical trial have been little explored.
Methods We conducted an anonymous survey from the 11th of September to the 11th of November 2020. Primary endpoint was the willingness to encourage pregnant women to participate in a hypothetical respiratory syncytial virus (RSV) vaccine clinical trial.
Results Among 398 midwives who answered the questionnaire, 113 (28.3 %) were likely to encourage pregnant women to participate in the vaccine clinical trial, this proportion ranged from 25 % in senior midwives to 34.5 % among the students. After adjustment on age, parenthood, previous vaccine hesitancy attitudes, and the 5 components of the 5C model, the only predictor of the promotion of the clinical trial was the training score with an adjusted odds ratio of 1.09 (1.01-1.18, p=0.027) for a one-point increase. Vaccine hesitancy and psychological antecedents of vaccinations were not associated with a lower promotion of pregnant women trial participation among midwives.
Conclusion Few respondents were likely to encourage pregnant women to participate in a vaccine clinical trial. Midwives who considered having a good training about vaccines were more prone to encourage pregnant women to participate in a RSV vaccine clinical trial.
Problem or Issue Recruitment of pregnant women in vaccine clinical trial is challenging
What is Already Known Pregnant women are more prone to accept participation in a clinical trial if the proposal is made by a midwife.
What this Paper Adds Evaluation of attitudes and their determinants of midwives about vaccine clinical trial participation of pregnant women.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
There is no funding for this work
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was given by our local Institution Review Board "Terre d'Ethique" at the University Hospital of Saint-Etienne, France IRBN1192020/CHUSTE.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data are available after contact with the corresponding author
